CTI BioPharma Corp Share Price Nasdaq
Equities
US12648L1061
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2023 | DRI Healthcare Trust Receives US$54.8 Million in Debt Repayment | MT |
2023 | DRI Healthcare Trust Brief: Announcing US$54.8 Million Debt Repayment from CTI BioPharma Corp. | MT |
Latest transcript on CTI BioPharma Corp
Managers | Title | Age | Since |
---|---|---|---|
Adam Craig
CEO | Chief Executive Officer | 58 | 20/17/20 |
David Kirske
DFI | Director of Finance/CFO | 69 | 01/17/01 |
John Volpone
HRO | Human Resources Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Adam Craig
CEO | Chief Executive Officer | 58 | 20/17/20 |
Laurent Fischer
CHM | Chairman | 60 | 21/17/21 |
David Parkinson
BRD | Director/Board Member | 73 | 05/17/05 |
1st Jan change | Capi. | |
---|---|---|
+26.90% | 4.92TCr | |
+0.99% | 4.21TCr | |
+50.47% | 4.04TCr | |
-5.26% | 2.89TCr | |
+13.80% | 2.61TCr | |
-22.32% | 1.87TCr | |
+7.73% | 1.33TCr | |
+32.50% | 1.23TCr | |
+0.29% | 1.2TCr |